Manipal Health IPO: Aims for $13B Valuation with $1B Listing

India's Largest Hospital Chain Sets Sights on Public Markets

Manipal Health Enterprises Pvt. Ltd., backed by Singapore's sovereign fund Temasek, has filed its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI), signaling its intent to launch an Initial Public Offering (IPO). The move is poised to create the largest public listing by a hospital operator in India, with the company seeking to raise over $1 billion and targeting a valuation of up to $13 billion (approximately ₹1.2 lakh crore).

This landmark IPO comes at a time of mixed sentiment in the broader equity markets but reflects strong underlying investor confidence in India's rapidly growing healthcare sector. If successful, Manipal Health could become the country's most valuable publicly traded hospital chain, surpassing the current leader, Max Healthcare Institute Ltd.

A Closer Look at the IPO Structure

The public offering is structured with two main components: a fresh issue of shares and an Offer for Sale (OFS) by existing shareholders. The fresh issue aims to raise ₹8,000 crore ($152 million). The OFS component will see existing investors sell up to 43.23 million shares, which represents a 3.66% stake in the company.

Key investors participating in the OFS include TPG, Temasek, Ammar Sdn. Bhd., Novo Holdings Invest Asia, and Manipal Education and Medical Group India Pvt. Ltd. The filing also indicates that Manipal Hospitals may consider a pre-IPO placement of shares worth as much as ₹1,600 crore, which would reduce the size of the fresh issue if completed.

Strategic Use of IPO Proceeds

Manipal Health has outlined clear objectives for the capital raised through the fresh issue. A significant portion of the proceeds will be used to repay outstanding borrowings, strengthening the company's balance sheet. The remaining funds are earmarked for financing its recent acquisition of Sahyadri Hospitals, a key strategic move that expanded its footprint in western India.

This focused allocation of funds underscores the company's dual strategy of deleveraging its finances while simultaneously fueling its aggressive inorganic growth. The repayment of debt will provide greater financial flexibility for future expansion and operational investments.

An Aggressive Path to Market Leadership

Manipal's journey to becoming India's largest hospital chain by bed capacity has been driven by a series of strategic acquisitions. The company has emerged as one of the most active consolidators in the Indian healthcare space. Its most recent major acquisition was Sahyadri Hospitals in 2025 for approximately ₹6,000 crore, which added 11 hospitals to its network.

Other notable acquisitions include an 84% stake in Kolkata-based AMRI Hospitals for around ₹2,400 crore in 2023, which solidified its presence in eastern India. The company also acquired an 87% stake in Medica Synergie for an estimated ₹1,400 crore and bought Vikram Hospital in Bengaluru for ₹360 crore in 2021. This acquisition-led growth has been instrumental in scaling its operations and market reach across the country.

Key IPO Details at a Glance

Manipal's Expansive Network

Following its rapid expansion, Manipal Health now operates a network of over 49 hospitals with a combined capacity exceeding 10,600 beds. This scale has allowed it to surpass Apollo Hospitals in terms of bed capacity. The group's interests are diversified, spanning healthcare, education, and insurance, providing a robust ecosystem for growth. With planned greenfield projects in Bengaluru, Mumbai, and Raipur, the hospital chain aims to expand its footprint to approximately 15,000 beds.

Investor Confidence and Market Dynamics

The decision to proceed with the IPO, despite recent market volatility and a slowdown in listings, highlights the sustained investor appetite for the Indian healthcare sector. The industry is witnessing a boom, fueled by rising demand for specialized medical care and significant private and foreign investments from global firms like Blackstone, KKR, and Novo Nordisk.

Temasek's decision to increase its stake in Manipal from 41% to 59% in 2023 for over $1 billion was a strong vote of confidence in the company's growth trajectory. The IPO will be managed by a consortium of leading investment banks, including Kotak Mahindra Capital, Axis Bank, Goldman Sachs, JPMorgan Chase & Co., and Jefferies Financial Group Inc.

The Road Ahead for Manipal

With the DRHP filed, all eyes are now on the regulatory approval process and the subsequent launch of the IPO. The offering will serve as a crucial test of the market's appetite for large-scale healthcare listings in the current economic climate. A successful listing would not only provide Manipal with the capital to pursue its growth ambitions but also set a new benchmark for valuations in the Indian hospital industry.